5OP5

Structure of CHK1 10-pt. mutant complex with pyrrolopyrimidine LRRK2 inhibitor

5OP5 の概要

• エントリーDOI: 10.2210/pdb5op5/pdb
• 関連するPDBエントリー: 5OOP 5OOR 5OOT 5OP2 5OP4
• 分子名称: Serine/threonine-protein kinase Chk1, 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile, CHLORIDE ION, ... (4 entities in total)
• 機能のキーワード: parkinson's disease, leucine-rich repeat kinase 2, lrrk2, checkpoint kinase 1, chk1, mutant, surrogate, kinase inhibitor, transferase
• 由来する生物種: Homo sapiens (Human)
• 細胞内の位置: Nucleus: O14757
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 34434.99

構造登録者

Dokurno, P.,Williamson, D.S.,Acheson-Dossang, P.,Chen, I.,Murray, J.B.,Shaw, T.,Surgenor, A.E. (登録日: 2017-08-09, 公開日: 2017-10-25, 最終更新日: 2024-01-17)

• 主引用文献: Williamson, D.S.,Smith, G.P.,Acheson-Dossang, P.,Bedford, S.T.,Chell, V.,Chen, I.J.,Daechsel, J.C.A.,Daniels, Z.,David, L.,Dokurno, P.,Hentzer, M.,Herzig, M.C.,Hubbard, R.E.,Moore, J.D.,Murray, J.B.,Newland, S.,Ray, S.C.,Shaw, T.,Surgenor, A.E.,Terry, L.,Thirstrup, K.,Wang, Y.,Christensen, K.V.; Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1).; J. Med. Chem., 60:8945-8962, 2017; PubMed: 29023112; DOI: 10.1021/acs.jmedchem.7b01186

実験手法

X-RAY DIFFRACTION (1.9 Å)